The corporate strategy of Strategy, formerly known as MicroStrategy, has once again drawn market attention. Last week, the issuer sold 3.46 million shares of Class MSTR common stock, raising $333.7 million, but contrary to many analysts' expectations, not a single dollar from this amount was directed toward purchasing bitcoins. This is the first significant signal of a pause in the aggressive accumulation policy the company has pursued over the past few years.

Instead of expanding its cryptocurrency portfolio, management decided to strengthen liquidity in fiat assets. Of the proceeds, $149.1 million were allocated to replenish the dollar reserve, which has now reached $4.8 billion. Additionally, $52.4 million went toward dividend payments on STRC preferred shares, and $132.2 million were used for a buyback program of the same securities. This capital reallocation indicates a shift in priorities: the company is clearly preparing for potential volatility or seeking opportunities for targeted acquisitions at more attractive prices.

Strategy's balance sheet still holds 840,447 BTC, making it the largest public holder of the leading cryptocurrency. However, the average purchase price of $75,385 per coin now looks burdensome: at current market quotes, the "paper" loss on the reserve is estimated at around $10 billion. This is a serious psychological threshold that likely prompts management to exercise caution, avoiding an increase in the average position cost amid a downtrend.

My analytical perspective

The pause in purchases is not a rejection of the strategy but a tactical breather. Having $4.8 billion in cash gives Strategy a unique opportunity to average down its position in the event of a deep correction, which could become a powerful catalyst for MSTR stock growth in the medium term. However, investors should closely monitor the company's actions: if the fiat reserve continues to grow without conversion into BTC, it could signal a shift in long-term vision, undermining the confidence of hardcore crypto enthusiasts.